Austrian oil and gas company OMV has finalised an agreement to supply natural gas from its Neptun Deep project in the Black ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease (TED).

Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.